Endari® Receives Kuwaiti Marketing Authorization

Kuwait is Third Gulf Cooperation Council Country to Approve Endari® TORRANCE Calif., Dec. 7, 2022 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received Registration Approval from the Pharmaceutical and…